Latest news articles

Added 1 year ago Drug news

Phase III COMPASS study shows Xarelto (rivaroxaban)+ aspirin significantly reduced major CV events.- Janssen Research Development + Bayer HealthCare.

Results from the pivotal Phase III COMPASS study found that the Xarelto (rivaroxaban) vascular dose (2.5 mg twice daily) plus...

Added 2 years ago Drug news

Phase III COMPASS trial of Xarelto (rivaroxaban) for the prevention of major adverse cardiac events stopped early- Janssen

Janssen Research & Development announced that the Phase III COMPASS trial, evaluating the efficacy and safety of Xarelto (rivaroxaban) for...

Search all news articles for Transient cerebral ischaemia
 

Learning Zones

An epgonline.org Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

Migraine Knowledge Centre

Migraine Knowledge Centre

The Migraine Knowledge Centre features latest research on the prevalence and impact of migraine, the proposed neurological basis of the condition (and how this is being translated into new and exciting drug therapies), as well as current patient care strategies collated from headache organisations worldwide.

Cushing's Syndrome

Cushing's Syndrome

Cushing’s syndrome shares symptoms such as hypertension, glucose intolerance and obesity with other common conditions – how can you confidently diagnose this rare disorder?

+ 2 more

Load more

Guidelines

Management of Atherosclerotic Carotid and Vertebral Artery Disease: 2017 Clinical Practice Guidelines of the European Society for Vascular Surgery (ESVS)

The European Society for Vascular Surgery (ESVS) has prepared guidelines for treating patients with atherosclerotic carotid and vertebral artery (VA) disease.

Added 1 year ago

National Clinical Guideline for Stroke, fifth edition 2016

The guideline provides a comprehensive examination of stroke care, encompassing the whole of the stroke pathway from acute care through to longer-term rehabilitation, including secondary prevention.

Added 6 years ago

Antithrombotics: indications and management

This guideline provides recommendations based on current evidence for best practice in the management of adult patients on antithrombotic therapy.

Added 5 years ago

Search all guidelines for Transient cerebral ischaemia
 

Journal articles

Global Prospective Safety Analysis of Rivaroxaban.

This study sought to assess the real-world safety profile of rivaroxaban through a pooled analysis of patients with AF enrolled in the XANTUS (Xarelto for Prevention of Stroke in Patients With Atrial Fibrillation) program worldwide.

Added 7 months ago

Optimal pharmacological therapy in ST-elevation myocardial infarction-a review : A review of antithrombotic therapies in STEMI.

Antithrombotic therapy is an essential component in the optimisation of clinical outcomes in patients with ST-elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention.

Added 10 months ago

Thrombectomy 6 to 24 Hours after Stroke with a Mismatch between Deficit and Infarct.

The effect of endovascular thrombectomy that is performed more than 6 hours after the onset of ischemic stroke is uncertain. Patients with a clinical deficit that is disproportionately severe relative to the infarct volume...

Added 1 year ago

Search all journal articles for Transient cerebral ischaemia
 

Clinical trials

Clinical Mismatch in the Triage of Wake Up and Late Presenting Strokes Undergoing Neurointervention With Trevo (DAWN)

The purpose of the study is to evaluate the hypothesis that Trevo thrombectomy plus medical management leads to superior clinical outcomes at 90 days as compared to medical management alone in appropriately selected subjects...

Added 1 year ago

Rivaroxaban for the Prevention of Major Cardiovascular Events in Coronary or Peripheral Artery Disease (COMPASS)

The primary purpose of this study is to evaluate whether treatment with rivaroxaban and aspirin or rivaroxaban alone is better than aspirin alone in prevention of heart attacks, stroke or cardiovascular death...

Added 7 years ago

An Efficacy and Safety Study for Rivaroxaban in Patients With Acute Coronary Syndrome

The purpose of this study is to determine whether rivaroxaban in addition to standard care reduces the risk of the composite of cardiovascular death, myocardial infarction, or stroke in patients...

Added 1 year ago

Search all clinical trials for Transient cerebral ischaemia
 

CME

Aspirin after TIA, probiotics, and yoga for asthma: journals update July 2016

Accrediting body
MIMS Learning - Monthly Index of Medical Specialities
Credits available
0
Registration required
1
Subscription fee
0

Transient ischaemic attack: clinical review

Accrediting body
MIMS Learning - Monthly Index of Medical Specialities
Credits available
2
Registration required
1
Subscription fee
0
Search all CME for Transient cerebral ischaemia